Perfero Pharma, Inc. NDCs and Package Codes
This page lists NDC package records associated with labeler code 87143 (Perfero Pharma, Inc.) — including active listings, ingredients, drug names, strengths, dosage forms, package sizes, pricing data when available, and links to each individual NDC page.
Key stats
4
Package NDCs
4
Products
4
Active listings
0
Discontinued
4
Ingredients
0
Therapeutic classes
3
Dosage forms
0
With NADAC pricing
Portfolio
Top ingredients
By dosage form
Browse records — 4 products
| Drug / product | Billing NDC | NADAC / unit | Status | |
|---|---|---|---|---|
| Attero calcipotriene and betamethasone dipropionate .05 mg/g; .5 mg/g SOLUTION | 87143-0100-60 | — | On market | View → |
| Evesse hydrocortisone butyrate 1 mg/mL LOTION | 87143-0420-04 | — | On market | View → |
| Pellix calcipotriene .05 mg/mL SOLUTION | 87143-0300-60 | — | On market | View → |
| Trilitas TAZAROTENE 1 mg/g GEL | 87143-0200-30 | — | On market | View → |
Where does this data come from?
NDC package records, ingredients, strengths and forms come from the openFDA NDC Directory, grouped by the 5-digit labeler code; pricing is CMS NADAC. This is a factual data directory, not a manufacturer marketing page.